TPW
IBB icon

Transatlantique Private Wealth’s iShares Biotechnology ETF IBB Stock Holding History

Transatlantique Private Wealth’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$507K Buy
3,003
+313
+12% +$50.8K 0.16% 154
2025
Q3 		$388K Buy
2,690
+10
+0.4% +$1.36K 0.13% 180
2025
Q2 		$339K Buy
2,680
+302
+13% +$37.1K 0.12% 180
2025
Q1 		$304K Sell
2,378
-174
-7% -$23.6K 0.12% 187
2024
Q4 		$337K Buy
2,552
+764
+43% +$107K 0.13% 178
2024
Q3 		$260K Buy
1,788
+108
+6% +$15.6K 0.1% 193
2024
Q2 		$231K Buy
+1,680
New +$224K 0.09% 186

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Transatlantique Private Wealth's IBB Position: Q4 2025 in Review

Transatlantique Private Wealth increased its iShares Biotechnology ETF (IBB) stake by 12% in Q4 2025, buying an estimated $50.8K and bringing the position to 3,003 shares worth $507K. The position accounts for 0.16% of the portfolio, ranked #154.

Transatlantique Private Wealth first reported a position in IBB in Q2 2024 and has held it in 7 quarters since. 956 funds tracked by Wall St. Rank hold IBB as of Q4 2025.

  • Transatlantique Private Wealth held 3,003 shares of iShares Biotechnology ETF worth $507K as of Q4 2025.
  • Transatlantique Private Wealth bought 313 iShares Biotechnology ETF shares in Q4 2025, an estimated $50.8K.
  • iShares Biotechnology ETF made up 0.16% of Transatlantique Private Wealth's portfolio in Q4 2025, its #154 holding.
  • Transatlantique Private Wealth first reported a position in iShares Biotechnology ETF in Q2 2024 and has held it in 7 quarters since.
  • 956 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2025.

Based on Transatlantique Private Wealth's 13F filing for Q4 2025, filed 10 Feb 2026.